Claims Under Fire;
<h3>The future of embryonic stem cell research in the U.S. may hinge on the current review of key patents</h3><p class="source">Chemical & Engineering News</p>
<p>The California initiative is also what led Santa Monica-based FTCR to get involved. John M. Simpson, director of the Stem Cell Project at FTCR, learned about the WARF patents while preparing a policy report on what intellectual property rules California should put in place to protect the state' s interests in research resulting from initiative grants.</p>
